Insider at JCI (NYSE: JCI) files Form 144 to sell 21,595 shares

Rhea-AI Filing Summary

JCI reported a planned Rule 144 sale of 21,595 ordinary shares through Morgan Stanley Smith Barney LLC on the NYSE, with an approximate sale date of 12/10/2025. The filing lists an aggregate market value of about 2,504,940.10 for these shares and notes that 611,135,665 shares of the same class were outstanding. The shares to be sold come from restricted stock vesting under a registered plan, with 14,608 shares acquired on 12/05/2025, 1,549 shares on 12/08/2025, and 5,438 shares on 12/06/2024, all as compensation for services rendered.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary Shares	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	21595	2504940.10	611135665	12/10/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary Shares	12/05/2025	Restricted stock vesting under a registered plan	Issuer			14608	12/05/2025	Services Rendered
Ordinary Shares	12/08/2025	Restricted stock vesting under a registered plan	Issuer			1549	12/08/2025	Services Rendered
Ordinary Shares	12/06/2024	Restricted stock vesting under a registered plan	Issuer			5438	12/06/2024	Services Rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does JCI's Form 144 filing disclose?

The Form 144 for JCI discloses a planned sale of 21,595 ordinary shares on the NYSE under Rule 144, using Morgan Stanley Smith Barney LLC as broker.

How many JCI shares are planned to be sold and what is their value?

The notice covers 21,595 ordinary shares of JCI with an aggregate market value of approximately 2,504,940.10.

How many JCI shares of this class are outstanding?

The filing states that there are 611,135,665 ordinary shares outstanding, providing context for the size of the planned Rule 144 sale.

When is the planned sale of JCI shares expected to occur?

The approximate date of sale listed in the Form 144 is 12/10/2025, with the shares to be sold on the NYSE.

How were the JCI shares being sold under Form 144 acquired?

The shares were acquired as restricted stock vesting under a registered plan from the issuer in exchange for services rendered on 12/06/2024, 12/05/2025, and 12/08/2025.

Which broker is handling the planned JCI share sale?

The Form 144 lists Morgan Stanley Smith Barney LLC Executive Financial Services, based at 1 New York Plaza, 8th Floor, New York, NY 10004, as the broker for the sale.